[BVD situation on farms with high serological values in the tank milk - individual animals have a greater influence than previously known]. / BVD-Situation auf Betrieben mit hohen serologischen Werten in der Tankmilch ­ Einzeltiere haben einen grösseren Einfluss als bisher bekannt.

INTRODUCTION: Bovine virus diarrhea (BVD) is an economically important disease in cattle. Switzerland started an eradication program in 2008. After the initial virological examination of all cattle followed by the examination of all newborn calves, the BVD prevalence in 2012 was low enough to start serological monitoring. An unusually high number of increased tank milk values were observed during this serological monitoring in autumn 2019. No seropositive animals were found on most farms in the follow-up cattle group testing. The present study was designed in the form of a multiple case report to better assess the BVD situation in a herd after a serological tank milk result above the cut-off value. The tank milk of 13 farms with serological values above the cut-off value from the analyses in autumn 2019 was examined again with two different ELISA tests in spring 2020. In addition, at the same time blood samples were taken to obtain serological values of all adult cattle on the farm. The results of the two tests that were used to examine the tank milk samples correlated well with each another. The results of the tank milk serology showed a low correlation with the seroprevalence in the lactating cows, but no correlation with the seroprevalence of all adult animals in the herd. A single seropositive animal had a major influence on the results of the tank milk serology in some herds. In addition, correct tank milk sampling must be ensured because the representativeness of the tank milk sample is decisive for a meaningful result for the investigated farm. If the result of the tank milk test is above the cut-off value, the examination of a group of cattle is still the best way to identify a current infection in a herd.

INTRODUCTION: La diarrhée virale bovine (BVD) est une maladie des bovins économiquement importante. En Suisse, cette maladie fait l'objet d'un programme d'éradication depuis 2008. Après l'examen virologique initial de tous les bovins, suivi de l'examen de tous les veaux nouveau-nés, la prévalence de la BVD en 2012 était suffisamment faible pour permettre d'adapter le programme de surveillance et de procéder à un suivi sérologique des exploitations laitières. Un nombre inhabituellement grand de valeurs élevées dans les examens de lait de citerne a été observé lors de cette surveillance sérologique en automne 2019. Dans de nombreuses exploitations, aucun animal séropositif n'a pu être découvert lors des tests de suivi des groupes de bovins. Cette étude a été conçue sous la forme d'un rapport de cas multiples pour mieux évaluer la situation de la BVD dans un troupeau après un résultat sérologique de lait de citerne supérieur à la valeur limite. Le lait de citerne de 13 exploitations avec des valeurs sérologiques supérieures à la valeur limite en automne 2019 a été analysé à nouveau avec deux tests ELISA différents au printemps 2020. De plus, des échantillons de sang ont été prélevés en même temps pour obtenir les valeurs sérologiques de tous les bovins adultes présents sur l'exploitation. Les résultats des deux tests utilisés pour examiner les échantillons de lait de citerne montraient une bonne corrélation entre les deux tests. Les résultats de la sérologie du lait de citerne ont montré une faible corrélation avec la séroprévalence chez les vaches en lactation mais pas avec la séroprévalence de tous les animaux adultes du troupeau. Un seul animal séropositif pouvait avoir à lui seul une forte influence sur les résultats de la sérologie du lait de citerne dans certains troupeaux. De plus, un prélèvement correct du lait de citerne doit être assuré car la représentativité de l'échantillon est décisive pour obtenir un résultat significatif pour l'exploitation étudiée. Si le résultat du test est supérieur à la valeur limite, l'examen d'un groupe de bovins reste le meilleur moyen d'identifier une infection dans un troupeau.

Economic comparison of the monitoring programmes for bluetongue vectors in Austria and Switzerland.

With the bluetongue virus serotype 8 (BTV-8) outbreak in 2006, vector monitoring programmes (according to EU regulation 1266/2007) were implemented by European countries to obtain information on the spatial distribution of vectors and the vector-free period. This study investigates the vector monitoring programmes in Austria and Switzerland by performing a retrospective cost analysis for the period 2006-2010. Two types of costs were distinguished: costs financed directly via the national bluetongue programmes and costs contributed in-kind by the responsible institutions and agricultural holdings. The total net costs of the monitoring programme in Austria amounted to €1,415,000, whereby in Switzerland the costs were valued at €94,000. Both countries followed the legislation complying with requirements, but differed in regard to sampling frequency, number of trap sites and sampling strategy. Furthermore, the surface area of Austria is twice the area of Switzerland although the number of ruminants is almost the same in both countries. Thus, for comparison, the costs were normalised with regard to the sampling frequency and the number of trap sites. Resulting costs per trap sample comprised €164 for Austria and €48 for Switzerland. In both countries, around 50 per cent of the total costs can be attributed to payments in-kind. The benefit of this study is twofold: first, veterinary authorities may use the results to improve the economic efficiency of future vector monitoring programmes. Second, the analysis of the payment in-kind contribution is of great importance to public authorities as it makes the available resources visible and demonstrates how they have been used.

Seroprevalence of hepatitis E virus in domestic pigs and wild boars in Switzerland.

Hepatitis E is considered an emerging human viral disease in industrialized countries. Studies from Switzerland report a human seroprevalence of hepatitis E virus (HEV) of 2.6-21%, a range lower than in adjacent European countries. The aim of this study was to determine whether HEV seroprevalence in domestic pigs and wild boars is also lower in Switzerland and whether it is increasing and thus indicating that this zoonotic viral infection is emerging. Serum samples collected from 2,001 pigs in 2006 and 2011 and from 303 wild boars from 2008 to 2012 were analysed by ELISA for the presence of HEV-specific antibodies. Overall HEV seroprevalence was 58.1% in domestic pigs and 12.5% in wild boars. Prevalence in domestic pigs was significantly higher in 2006 than in 2011. In conclusion, HEV seroprevalence in domestic pigs and wild boars in Switzerland is comparable with the seroprevalence in other countries and not increasing. Therefore, prevalence of HEV in humans must be related to other factors than prevalence in pigs or wild boars.

[Does emergency vaccination make sense as a supporting element in control of foot-and-mouth disease in Switzerland]. / Ist die Notimpfung als unterstützende Massnahme zur Tilgung der Maul- und Klauenseuche in der Schweiz sinnvoll?

The outbreak of foot and mouth disease (FMD) in Great Britain in 2001 let to discussions and especially emergency vaccination was deemed as an alternative to the culling of vast numbers of healthy animals. The project emergency vaccination for FMD in Switzerland was conducted to compare the effectiveness of conventional control strategies during a FMD outbreak alone and with ring vaccination of 3 km and 10 km, respectively. The results of this project showed that emergency vaccination conducted at the beginning of an epidemic was not favorable compared to conventional disease control strategy in Switzerland. In case of an advanced FMD epidemic, a 10 km ring vaccination could support the disease control in a positive way. However, the goal of emergency vaccination to save animal live can hardly be achieved due to actual legal basis and the consequent restriction measures within vaccination zones which will lead to welfare culling.

L'épizootie de fièvre aphteuse en Grande Bretagne en 2001 a montré que les abatages de masse d'animaux sains sont plus en plus critiquée. On discute régulièrement de la vaccination d'urgence comme mesure permettant de réduire le nombre d'animaux à tuer en cas d'épizootie. Dans le cadre du projet vaccination d'urgence FA suisse, on a comparé l'effet de la seule lutte conventionnelle avec celui d'une vaccination d'urgence «vaccination to live¼ dans un périmètre de 3 km (GV3) respectivement 10 km (GV10) quant à la durée et à l'importance du foyer. Au début d'une épizootie, la vaccination d'urgence supplémentaire n'apporte pas d'avantage face à la lutte conventionnelle. Si une vaccination V10 est pratiquée plus tardivement, elle peut dans certains cas amener une diminution et un raccourcissement de l'épizootie. Le but visant, grâce à la vaccination d'urgence, à tuer moins d'animaux ne peut toutefois pas, dans les conditions actuelles, être atteint car vu les fortes limitations du trafic d'animaux à l'intérieur des zones de vaccination, on doit compter avec des abattages pour des raisons de protections des animaux.

Data management systems for the bovine viral diarrhoea eradication programme in Switzerland.

A programme to eradicate bovine viral diarrhoea was launched in Switzerland in 2008 with the aim of eradicating the causal virus. During the first year of the programme, the entire population of 1.6 million cattle were tested for the presence of the virus; in the following three years an additional 1.8 million calves were tested. The complexity of information generated during the eradication programme, together with a tight schedule, made computerised data management a necessity. To organise, coordinate and supervise the programme, extensions were made to the computerised information system ISVet, of the Swiss Veterinary Service, which provides automated documents for both the Veterinary Service and private veterinarians. Specific data are accessible by user groups via the BVD-Web platform, ISVet and the Swiss animal movement database. The functionalities of the structure and the reports needed to control the progress of the programme are described in detail. The authors also discuss the major advantages, disadvantages and pitfalls when planning an eradication programme using a national centralised database over a distributed computer network.

Cost-effectiveness of bulk-tank milk testing for surveys to demonstrate freedom from infectious bovine rhinotracheitis and bovine enzootic leucosis in Switzerland.

In Switzerland, annual surveys to substantiate freedom from infectious bovine rhinotracheitis (IBR) and enzootic bovine leucosis (EBL) are implemented by a random allocation of farms to the respective survey as well as blood sampling of individual animals at farm level. Contrary to many other European countries, bulk-tank milk (BTM) samples have not been used for active cattle disease surveillance for several years in Switzerland. The aim of this project was to provide a financial comparison between the current surveillance programme consisting of blood sampling only and a modified surveillance programme including BTM sampling. A financial spreadsheet model was used for cost comparison. Various surveillance scenarios were tested with different sample sizes and sampling frequencies for BTM samples. The costs could be halved without compromising the power to substantiate the freedom from IBR and EBL through the surveillance programme. Alternatively, the sensitivity could be markedly increased when keeping the costs at the actual level and doubling the sample size. The risk-based sample size of the actual programme results in a confidence of 94,18 % that the farm level prevalence is below 0,2 %. Which the doubled sample size, the confidence is 99,69 % respectively.

Economic evaluation of the surveillance and intervention programme for bluetongue virus serotype 8 in Switzerland.

Empirical analyses founded on sound economic principles are essential in advising policy makers on the efficiency of resource use for disease mitigation. Surveillance and intervention are resource-using activities directed at mitigation. Surveillance helps to offset negative disease effects by promoting successful intervention. Intervention is the process of implementing measures (e.g. vaccination or medication) to reduce or remove a hazard in a population. The scale and ratios in which the two are combined affect the efficiency of mitigation, its costs, benefits, and thus net effect on society's well-being. The Swiss national mitigation programme for bluetongue virus serotype 8 was used as case study to investigate the economic efficiency of mitigation. In 2008, Switzerland implemented a vaccination programme to avoid and reduce disease and infection in its ruminant population. To monitor the vaccination programme and the vector dynamics, a surveillance system consisting of serological and entomological surveillance was established. Retrospective analyses for the years 2008-2009 and prospective analyses for the years 2010-2012 were conducted to investigate if the mitigation programme was economically beneficial. In the retrospective analysis, the implemented programme (=comparative scenario) was compared to a hypothesised baseline scenario of voluntary vaccination and surveillance. In the prospective analysis, the comparative scenario assumed to continue was compared to two baseline scenarios: one of voluntary vaccination combined with surveillance and one of no vaccination combined with surveillance. For each scenario, monetary surveillance, intervention and disease costs were calculated. The comparison of baseline and comparative scenarios yielded estimates for the total benefit (=disease costs avoided), margin over intervention cost and the net value of the programme. For 2008-2009, in aggregate, the mean biannual total benefit was 17.46 m Swiss francs (CHF) (1CHF=0.66€ at the time of analysis) and the mean net benefit after subtraction of the intervention and surveillance cost was 3.95 m CHF. For the three years 2010-2012, overall net costs were estimated at 12.93 m and 8.11 m CHF, respectively, for comparison of the implemented mitigation programme with the two baseline scenarios. It was concluded that the surveillance and intervention programme implemented in 2008-2009 was economically beneficial, while its continuation in the same form in 2010-2012 would produce net costs. These costs were due to the mean intervention cost remaining constant at a level of approximately 11 m CHF per year while the mean total benefit would be gradually reduced in 2010-2012 due to the reduced occurrence of disease in a fully vaccinated population.

[Infectious bovine rhinotracheitis (IBR) in the canton of Jura: an epidemiological outbreak investigation]. / Rhino-trachéite infectieuse bovine (IBR) dans le canton du Jura: enquête épidémiologique.

Following an abortion in a beef herd in the summer of 2009, three outbreaks of infectious bovine rhinotracheitis (IBR) were diagnosed in the cantons of Jura and Neuchatel. An epidemiological outbreak investigation was conducted with the aims to identify the source of introduction of the bovine herpes virus 1 (BoHV-1) into the affected herds and to prevent further spread of the disease. The attack rates in the three outbreak farms were 0.89, 0.28 and 0, respectively. BoHV-1 could be isolated from nasal swabs of two animals originating from one of the affected farms. Comparative restriction enzyme analysis revealed slight differences between the isolates of the two animals, but a high similarity to previous BoHV-1 isolates from the canton of Jura, as well as to a French BoHV-1 isolate. This IBR outbreak has shown the importance of reporting and analyzing abortions. The current disease outbreaks recall the main risk factors for the spread of IBR in Switzerland: purchase and movement of bovines and semen of often unknown IBR status.

[African horse sickness and equine encephalosis: must Switzerland get prepared]. / Afrikanische Pferdepest und equine Encephalosis: Muss sich die Schweiz vorbereiten?

African horse sickness (AHS) of equines is partly transmitted by the same culicoides species as Bluetongue (BT) disease in even-toed ungulates. Horses normally get seriously sick, with a high case fatality rate. Equine Encephalosis is another, but less-known viral disease of equines, caused by viruses of the same genus as BT and AHS. Like BT of serotype 8 in 2006, both diseases could theoretically be introduced to Europe anytime and spread rapidly then. After the lessons learnt from the most recent bluetongue outbreaks in Europe, the regulations and AHS-contingency plans in force must be updated. All stakeholders must be aware of the risks and take own measures to prevent a possible emergence of the diseases, and be prepared in case of an outbreak.

Spatial distribution of bluetongue surveillance and cases in Switzerland.

Swiss Bluetongue surveillance from mid 2007 to mid 2008 was a combination of monthly bulk milk testing of 200 cattle herds in zones of higher risk for vector presence and intensification of passive clinical surveillance. The spatial scan statistic and Moran's I statistic were used to determine clustering of surveillance data. The results show a high level of surveillance intensity for BT in Switzerland in 2007. In the region encompassing the Cantons of Aargau, Basel-Landschaft, Basel-Stadt and Solothurn, where cases were detected in 2007, the surveillance was significantly higher than in the rest of Switzerland. Six cases of Bluetongue were detected within the surveillance system. The prevalence estimates 9.62% (95% CI = 3.25%-18.85% versus 0.98% (95% CI = 0.2%-2.22%) were also significantly higher in the area with higher surveillance intensity. Spatial variation in surveillance data should to be considered if a disease event is analysed on a national scale. The spatial variation of prevalence estimates should be considered in future Bluetongue surveillance in Switzerland.

Equine travellers to the Olympic Games in Hong Kong 2008: a review of worldwide challenges to equine health, with particular reference to vector-borne diseases.

The past 10-20 years have seen exponential growth in the volume of trade in horses and equine germplasm; and the extent of global horse movements has increased significantly in the last 4 years. In preparing for the transport of elite Olympic horses to Hong Kong in 2008, it will be very important to be as fully informed as possible of the disease situation in both the exporting and importing country, import and re-entry requirements, as well as having a vaccination strategy to protect against particular diseases. In this context the review describes the equine vector-borne disease situation in Europe, Asia, Africa and South America and provides estimates of the number of horse movements between these countries, as well as information on import requirements and vaccination strategies.

Cases of bovine spongiform encephalopathy born in Switzerland before and after the ban on the use of bovine specified risk material in feed.

In Switzerland there was a reduction in the number of cases of bovine spongiform encephalopathy, observed in the birth cohorts from 1995 to 1996, but no further reduction in the following birth cohorts up to 1998. From the records of 34 cases born after April 30, 1996 (BAB96) and 174 cases born before April 30, 1996 and after December 1990 (BAB90), observed up to April 30, 2004, the risk factors at the farm level, possible routes of exposure and the geographical distribution of the cases were analysed to try to explain the observations. No evidence was found for a rate of exposure other than feed. There was some evidence that the risk factors at farm level were different between the BAB90 and BAB96 cases. A large proportion of the BAB96 cases was born in cantons that had reported only a few BAB90 cases, but a small cluster of the BAB96 cases was found in a region where there had been a cluster of BAB90 cases. The spatial distribution of these cases indicated that the risk of exposure to infection had been more randomly distributed than during the period up to April 1996. Farms with mixed livestock had a higher risk of having a case born after the ban on the feeding of specified risk material in 1996. In a regression model, a trend towards an association between cases of BSE and presence of small ruminants on the farm was observed for the BAB96 cases, and the presence of pigs and the pig:cattle ratio were significant for the BAB90 cases.

[Geographic distribution of BSE in Switzerland]. / Räumliche Verteilung der BSE in der Schweiz.

Visual evaluation of the occurrence of BAB (born after ban) cases pointed towards spatial clustering. Therefore a statistical analysis of spatial case clustering was conducted using GIS technology. In the initial analysis, all 376 cases (135 BAB, 241 BBB/born before ban) diagnosed through mid of March 2001 were investigated using the spatial scan statistic. Two clusters of BBB cases were identified in the western part of Switzerland, and two clusters of BAB cases in the eastern part. Epidemiological investigations performed within the BAB clusters showed an increased pig density in these cluster regions. Pig density is considered an indicator for the probability of contamination of cattle feed with feed containing meat-and-bone meal that is intended for other species (cross-contamination). In an updated cluster analysis including all cases reported until end of June 2002 (data set B), clusters were identified in the same regions as previously. It was shown that the BAB clusters occurred in different time periods. The small scale differences in cluster size and location are discussed, with an emphasis on the implications for following epidemiological investigations.

[Twelve years experience in Switzerland: Quo vadis BSE?]. / Zwölf Jahre Erfahrung in der Schweiz: Quo vadis BSE?

When the first BSE case in Switzerland became public in 1990, it precipitated a chain of events with many diverse consequences. During this time, we continued to gain knowledge, implement new measures, and make practical recommendations in order to attempt to control the disease. This was made possible by the establishment of a huge data base containing information on all cases of BSE that had been diagnosed in Switzerland, as well as by the use of information from experiences in other countries. Analysis of these data allowed the sequence of events to be described temporally and spatially and an epidemiological evaluation to be made. These data also allow predictions to be made regarding the future of BSE in Switzerland, although these predictions must be interpreted cautiously.